-
Mashup Score: 3
Could various kinds of cell therapy help patients facing COVID-19? In theory maybe, but it’s a long shot. Today’s post covers new developments here.
Source: The NicheCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 5Coronavirus (COVID-19) Update: FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19 - 4 year(s) ago
The FDA issued an EUA for two monoclonal antibodies to be administered together for treating mild to moderate COVID-19 in adults and pediatric patients.
Categories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 8
Early reports showed high mortality from Covid-19; by contrast, the current outbreaks in the southern and western United States are associated with fewer deaths, raising hope that treatments have improved. However, in Texas for instance, 63% of diagnosed cases are currently under 50, compared to only 52% nationally in March-April. Current demographics in Arizona and Florida are similar….
Source: medRxivCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 1
They’ve been promoted as a “bridge to a vaccine.” But what are monoclonal antibodies?
Source: NBC NewsCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 13FDA Green-Lights Clinical Trial For COVID-19 Coronavirus Treatment That ‘Flattens The Curve’ In Patients - 4 year(s) ago
Immunotherapy startup Celuarity announced the FDA has cleared its application for an investigational new stem-cell therapy against COVID-19.
Source: ForbesCategories: Future of Medicine, Latest HeadlinesTweet
Cell therapy trials for COVID-19 accelerate & some early reports. #COVID19 #Immunotherapy #TreatTheCurve https://t.co/XRO3UvYQXe